A rare presentation of biclonal gammopathy in primary mediastinal lymph node plasmacytoma: A case report

Youssra El Amrani 1, 2, Btissam Ait Boucetta 1, 2, Imane El Khannouri 1, 2, Saliha Chellak 1, 2 and Abderrahmane Boukhira 1, 2

1 Laboratory of Biochemistry and Toxicology, Avicenna Military Hospital, Marrakesh, Morocco.
2 Faculty of Medicine and Pharmacy of Marrakech. University Cadi Ayyad Marrakesh, Morocco.
 
Case Study
GSC Biological and Pharmaceutical Sciences, 2024, 29(02), 299–303.
Article DOI: 10.30574/gscbps.2024.29.2.0439
 

 

Publication history: 
Received on 04 October 2024; revised on 18 November 2024; accepted on 21 November 2024
 
Abstract: 
Primary plasmacytomas are localized proliferations of clonal plasma cells occurring in the absence of a systemic plasma cell dyscrasia, such as multiple myeloma. They most commonly manifest as solitary lesions in the bone or in the upper aerodigestive tract. Presentation in a lymph node is quite rare, especially when it involves the mediastinum. We report the case of a 32-year-old woman presenting with worsening dyspnea, cough, and chest discomfort, with radiologic evidence of mediastinal enlargement. An excisional biopsy of a large mediastinal mass revealed a plasma cell infiltrate, while protein electrophoresis analysis showed a biclonal gammopathy of the IgG kappa and IgA lambda type. She was treated with a myeloma-like regimen consisting of four cycles of bortezomib/dexamethasone followed by two cycles of thalidomide/prednisone, resulting in improvement of symptoms and complete resolution of lymphadenopathy. She remained in remission over 18 months following completion of therapy. This case report illustrates an unusual instance of biclonal gammopathy in primary mediastinal lymph node plasmacytoma, emphasizing its unique presentation and successful treatment through systemic therapy.
 
Keywords: 
Primary plasmacytoma; Mediastinal lymph node; Biclonal gammopathy; Plasma cell; Paraproteinemia
 
Full text article in PDF: 
Share this